Detalhe da pesquisa
1.
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma.
J Eur Acad Dermatol Venereol
; 38(1): 93-101, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625814
2.
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.
Oncologist
; 28(8): e617-e624, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971495
3.
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
BMC Cancer
; 23(1): 121, 2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747118
4.
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy.
Br J Dermatol
; 188(1): 112-121, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689499
5.
First-line programmed death receptor-1 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage IV penile cancer.
BJU Int
; 131(2): 198-207, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704436
6.
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
Ann Surg Oncol
; 29(8): 5221-5234, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397739
7.
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study.
BMC Cancer
; 22(1): 565, 2022 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596181
8.
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Gastric Cancer
; 24(4): 913-925, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945049
9.
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
Ann Surg Oncol
; 27(9): 3478-3485, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253677
10.
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.
BMC Cancer
; 20(1): 219, 2020 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171288
11.
Development of 99mTc-conjugated JS001 antibody for in vivo mapping of PD-1 distribution in murine.
Bioorg Med Chem Lett
; 29(16): 2178-2181, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31257084
12.
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data.
Future Oncol
; 15(1): 53-63, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30058839
13.
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
Cancer Sci
; 109(6): 1787-1798, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660787
14.
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
Ann Surg Oncol
; 25(4): 885-893, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29270879
15.
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
Ann Surg Oncol
; 25(8): 2184-2192, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748886
16.
Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors.
BMC Cancer
; 17(1): 16, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28056874
17.
[A pilot study of sunitinib as first-line therapy for metastatic renal cell carcinoma on a 2 weeks on/1 week off intermittent dosing schedule].
Zhonghua Zhong Liu Za Zhi
; 37(5): 375-8, 2015 May.
Artigo
em Zh
| MEDLINE | ID: mdl-26463030
18.
[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma].
Zhonghua Yi Xue Za Zhi
; 95(30): 2459-61, 2015 Aug 11.
Artigo
em Zh
| MEDLINE | ID: mdl-26711209
19.
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma.
BMC Cancer
; 14: 376, 2014 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886512
20.
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.
Mol Ther
; 21(7): 1456-63, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23670576